SHAREHOLDER ALERT: Weiss Law Investigates Natus Medical Incorporated

NEW YORK, April 18, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Natus Medical Incorporated ("Natus" or the "Company") (NASDAQ: NTUS), in connection with the proposed acquisition of the Company by an affiliate of ArchiMed. Under the terms of the merger agreement, the Company's shareholders will receive $33.50 in cash for each share of Natus common stock owned. The transaction is valued at $1.2 billion.

Read more at prnewswire.com